18F-MCL-524, an 18F-labeled dopamine D2and D3 receptor agonist sensitive to dopamine: A preliminary PET study

Journal of Nuclear Medicine

Volumn 55, Issue 7, 2014, Pages 1164-1170

  Finnema, Sjoerd J ^a   Stepanov, Vladimir ^a   Nakao, Ryuji ^a   Sromek, Anna W ^b   Zhang, Tangzhi ^b   Neumeyer, John L ^b   George, Susan R ^c   Seeman, Philip ^c   Stabin, Michael G ^d   Jonsson, Cathrine ^e   Farde, Lars ^a   Halldin, Christer ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b MCLEAN HOSPITAL   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d VANDERBILT UNIVERSITY   (United States)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Agonist; Dopamine; Monkey, PET

Indexed keywords

2 FLUOROETHOXY N N PROPYLNORAPOMORPHINE F 18; CARBON MNPA C 11; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; RADIOLIGAND; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; 2-FLUOROETHOXY-N-N-PROPYLNORAPOMORPHINE; APOMORPHINE; NORAPOMORPHINE;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DOSIMETRY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; ISOTOPE ANALYSIS; ISOTOPE LABELING; MACACA FASCICULARIS; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; RADIOASSAY; RADIOISOTOPE DISTRIBUTION; RADIOSENSITIVITY; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; KINETICS; METABOLISM; PROCEDURES; RADIOCHEMISTRY; RADIOMETRY;

ANIMALS; APOMORPHINE; DOPAMINE; ISOTOPE LABELING; KINETICS; MACACA FASCICULARIS; POSITRON-EMISSION TOMOGRAPHY; RADIOCHEMISTRY; RADIOMETRY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3;

EID: 84904104728     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.113.133876     Document Type: Article

References (32)

1. De Lean A, Kilpatrick BF, Caron MG. Dopamine receptor of the porcine anterior pituitary gland: evidence for two affinity states discriminated by both agonists and antagonists. Mol Pharmacol. 1982;22:290-297. (Pubitemid 12028825)
2. George SR, Watanabe M, Di Paolo T, Falardeau P, Labrie F, Seeman P. The functional state of the dopamine receptor in the anterior pituitary is in the high affinity form. Endocrinology. 1985;117:690-697. (Pubitemid 15237891)
3. Kühl M, Finnemann S, Binder O, Wedlich D. Dominant negative expression of a cytoplasmically deleted mutant of XB/U-cadherin disturbs mesoderm migration during gastrulation in Xenopus laevis. Mech Dev. 1996;54:71-82. (Pubitemid 26043174)
4. 2 receptors. Nucl Med Biol. 2000;27:533-539.
5. 11C]MNPA in cynomolgus monkey. Nucl Med Biol. 2005;32:353-360.
6. 11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4] oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography. J Med Chem. 2005;48:4153-4160.
7. Narendran R, Hwang DR, Slifstein M, et al. In vivo vulnerability to competition by endogenous dopamine: comparison of the D-2 receptor agonist radiotracer (-)-N-[C-11]propyl-norapomorphine ([C-11]NPA) with the D-2 receptor antagonist radiotracer [C-11]-raclopride. Synapse. 2004;52:188-208. (Pubitemid 38581669)
8. 11C]raclopride to measure amphetamine-induced dopamine release in the human striatum. J Pharmacol Exp Ther. 2010;333:533-539.
9. Judenhofer MS, Wehrl HF, Newport DF, et al. Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med. 2008;14:459-465. (Pubitemid 351499385)
10. Laruelle M. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab. 2000;20:423-451. (Pubitemid 30164887)
11. Finnema SJ, Bang-Andersen B, Wikstrom HV, Halldin C. Current state of agonist radioligands for imaging of brain dopamine D2/D3 receptors in vivo with positron emission tomography. Curr Top Med Chem. 2010;10:1477-1498.
12. Zijlstra S, Visser GM, Korf J, Vaalburg W. Synthesis and in vivo distribution in the rat of several fluorine-18 labeled N-fluoroalkylaporphines. Appl Radiat Isot. 1993;44:651-658. (Pubitemid 23089929)
13. Vasdev N, Seeman P, Garcia A, et al. Syntheses and in vitro evaluation of fluorinated naphthoxazines as dopamine D2/D3 receptor agonists: radiosynthesis, ex vivo biodistribution and autoradiography of [18F]F-PHNO. Nucl Med Biol. 2007;34:195-203. (Pubitemid 46241892)
14. 18F-5-OH-FPPAT) in rodents and nonhuman primates. Nucl Med Biol. 2004;31:303-311.
15. 2 receptors. ACS Med Chem Lett. 2011;2:189-194.
16. 11C]MNPA. J Labelled Comp Radiopharm. 2009;52:158-165.
17. Garber JC, Barbee RW, Bielitzki JT, et al. Guide for the Care and Use of Laboratory Animals. 8th ed. Washington DC: National Academies Press; 2011:1-220.
18. Finnema SJ, Stepanov V, Ettrup A, et al. Characterization of [C]Cimbi-36 as an agonist PET radioligand for the 5-HT and 5-HT receptors in the nonhuman primate brain. Neuroimage. 2014;84:342-353.
19. 18F-LBT-999: quantification, biodistribution, and radiation dosimetry in nonhuman primates. J Nucl Med. 2011;52:1313-1321.
20. Varrone A, Sjoholm N, Eriksson L, Gulyas B, Halldin C, Farde L. Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT. Eur J Nucl Med Mol Imaging. 2009;36:1639-1650.
21. 11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab. 2003;23:1096-1112.
22. 11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab. 1990;10:740-747.
23. Innis RB, Cunningham VJ, Delforge J, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007;27:1533-1539. (Pubitemid 47301451)
24. Foster D, Barrett P. Developing and testing integrated multicompartment models to describe a single-input multi-output study using the SAAM II software system. Mathematical Modeling in Experimental Nutrition. New York, NY: Springer; 1998:59-78.
25. Stabin MG, Siegel JA. Physical models and dose factors for use in internal dose assessment. Health Phys. 2003;85:294-310. (Pubitemid 36999340)
26. Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46:1023-1027. (Pubitemid 43733519)
27. Seneca N, Finnema SJ, Farde L, et al. Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: a comparison of the agonist radioligand [11C] MNPA and antagonist [11C]raclopride. Synapse. 2006;59:260-269. (Pubitemid 43271734)
28. 11C]MNPA: a dopamine agonist radioligand. Synapse. 2008;62:700-709.
29. 11C-propyl-norapomorphine in vivo binding in nonhuman primates. J Nucl Med. 2004;45:338-346.
30. 11C-NPA) determined from PET. J Nucl Med. 2009;50:814-817.
31. 18F-labeled PET tracers for first-in-human studies. Eur J Nucl Med Mol Imaging. 2013;40:1781-1783.
32. 11C-labeled PET tracers for first-in-human studies. Eur J Nucl Med Mol Imaging. 2012;39:544-547.